enow.com Web Search

  1. Ads

    related to: methazolamide use for essential tremor therapy

Search results

  1. Results from the WOW.Com Content Network
  2. PRAX-114 - Wikipedia

    en.wikipedia.org/wiki/PRAX-114

    As of March 2023, PRAX-114 is in phase 2/3 clinical trials for major depressive disorder and phase 2 clinical trials for essential tremor. [2] [3] [1] No recent development has been reported for treatment of depressive disorders and epilepsy. [2]

  3. Ulixacaltamide - Wikipedia

    en.wikipedia.org/wiki/Ulixacaltamide

    Ulixacaltamide is an investigational new drug developed by Praxis Precision Medicines, designed to treat essential tremor, [1] a common neurological disorder characterized by involuntary rhythmic shaking. It functions as a selective inhibitor of T-type calcium channels, which are implicated in the abnormal neuronal activity associated with ...

  4. Essential tremor - Wikipedia

    en.wikipedia.org/wiki/Essential_tremor

    Essential tremor (ET), also called benign tremor, familial tremor, and idiopathic tremor, is a medical condition characterized by involuntary rhythmic contractions and relaxations (oscillations or twitching movements) of certain muscle groups in one or more body parts of unknown cause. [6]

  5. Methazolamide - Wikipedia

    en.wikipedia.org/wiki/Methazolamide

    Methazolamide (trade name Neptazane) is a potent carbonic anhydrase inhibitor. It is indicated in the treatment of increased intraocular pressure (IOP) in chronic open-angle glaucoma and secondary glaucoma. Also it is used preoperatively in acute angle-closure (narrow-angle) glaucoma where lowering the IOP is desired before surgery.

  6. Deep brain stimulation - Wikipedia

    en.wikipedia.org/wiki/Deep_brain_stimulation

    DBS has been approved by the Food and Drug Administration as a treatment for essential and Parkinsonian tremor and since 1997, [3] and for Parkinson's disease (PD) since 2002. DBS was approved as humanitarian device exemptions for dystonia in 2003, [4] obsessive–compulsive disorder (OCD) in 2009, and approved for epilepsy in 2018.

  7. Thalamic stimulator - Wikipedia

    en.wikipedia.org/wiki/Thalamic_stimulator

    A thalamic stimulator is a medical device that can suppress tremors, such as those caused by Parkinson's disease or essential tremor. It was approved for use by the Food and Drug Administration (FDA) on August 4, 1997. Installation is invasive, so it is typically only used when the tremors are incapacitating, and medication is ineffective.

  1. Ads

    related to: methazolamide use for essential tremor therapy